ANY ADVANCED SOLID TUMORS

Clinical trials for ANY ADVANCED SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new ANY ADVANCED SOLID TUMORS trials appear

Sign up with your email to follow new studies for ANY ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Two-Drug attack tested against Tough-to-Treat cancers

Disease control Completed

This study tested a new combination of two drugs, NT-I7 and pembrolizumab, for people with advanced solid tumors that had returned or stopped responding to prior therapies. The main goals were to find a safe dose and see if the combination could shrink tumors in several hard-to-t…

Matched conditions: ANY ADVANCED SOLID TUMORS

Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ANY ADVANCED SOLID TUMORS

Get alerted when new ANY ADVANCED SOLID TUMORS trials appear

New Two-Drug attack tested against Tough-to-Treat cancers